| Mr Jeffrey Brian Krell, RPH | |
|
71 W Main St, Buckhannon, WV 26201-2236 | |
| (304) 472-0150 | |
| (304) 472-5286 |
| Full Name | Mr Jeffrey Brian Krell |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 71 W Main St, Buckhannon, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134426190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP0004517 (West Virginia) | Primary |
| 183500000X | Pharmacist | RP029533L (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jeffrey Brian Krell, RPH 71 W Main St, Buckhannon, WV 26201-2236 Ph: (304) 472-0150 | Mr Jeffrey Brian Krell, RPH 71 W Main St, Buckhannon, WV 26201-2236 Ph: (304) 472-0150 |
News Archive
A federal appeals court Tuesday lambasted the Department of Veterans Affairs for failing to care for those suffering post-traumatic stress disorder and ordered a major overhaul of the behemoth agency. Treatment delays for PTSD and other combat-related mental illnesses are so "egregious" that they violate veterans' constitutional rights and contribute to the despair behind many of the 6,500 suicides among veterans each year, the U.S. 9th Circuit Court of Appeals said in its 2-1 ruling.
The New York Times examines developments in circumcision technology, after "three studies have shown that circumcising adult heterosexual men is one of the most effective 'vaccines' against [HIV] - reducing the chances of infection by 60 percent or more."
Huntington disease (HD) is an inherited neurodegenerative disorder caused by a defect on chromosome four where, within the Huntingtin gene, a CAG repeat occurs too many times. Most individuals begin experiencing symptoms in their 40s or 50s, but studies have shown that significant brain atrophy occurs several years prior to an official HD diagnosis. As a result, the field has sought a preventive treatment that could be administered prior to the development of actual symptoms that might delay the onset of illness.
In an editorial published in CNS Spectrums, Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).
› Verified 4 days ago
Mrs. Rachel Batchelor, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Buckhannon Xrds, Buckhannon, WV 26201 Phone: 304-472-0834 | |
Mrs. Teresa Lynn Ferguson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 74 W Main St, Buckhannon, WV 26201 Phone: 304-473-0151 Fax: 304-473-0137 | |
Michelle Dasher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Amalia Dr, Buckhannon, WV 26201 Phone: 304-473-2051 | |
Eric Strother, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Amalia Dr, Buckhannon, WV 26201 Phone: 304-473-2151 | |
Dr. Nancy Bozic, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 W Main St, Buckhannon, WV 26201 Phone: 304-472-1712 Fax: 304-472-1715 | |
Dr. Casey Aaron Shrout, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 37 W Main St, Buckhannon, WV 26201 Phone: 304-472-1712 |